Filing Details
- Accession Number:
- 0001225208-18-001054
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-16 17:13:05
- Reporting Period:
- 2018-01-16
- Accepted Time:
- 2018-01-16 17:13:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310158 | Merck & Co. Inc. | MRK | Pharmaceutical Preparations (2834) | 221918501 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376841 | H Adam Schechter | Merck &Amp; Co., Inc. 2000 Galloping Hill Road Kenilworth NJ 07033 | Evp & Pres-Global Human Health | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-16 | 50,994 | $36.56 | 50,994 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-01-16 | 50,994 | $61.63 | 0 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-01-16 | 50,608 | $61.63 | 62,766 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-01-16 | 50,994 | $0.00 | 50,994 | $36.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 200,000 | 2012-05-04 | 2021-05-03 | No | 4 | M | Direct |
Footnotes
- The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
- Holdings include shares acquired in dividend reinvestment transactions.
- The option became exercisable in equal installments on 5/4/2012, 5/4/2013 and 5/4/2014.
Billionaire Hedge Funds
